Page last updated: 2024-10-31

neostigmine and Adie Syndrome

neostigmine has been researched along with Adie Syndrome in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Adie Syndrome: A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light (light-near dissociation) and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. (From Adams et al., Principles of Neurology, 6th ed, p279)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, O1
Lindberg, J1
Modigh, K1
Reske-Nielsen, E1

Reviews

1 review available for neostigmine and Adie Syndrome

ArticleYear
Subacute dysautonomia with incomplete recovery.
    Acta neurologica Scandinavica, 1972, Volume: 48, Issue:4

    Topics: Accommodation, Ocular; Acetylcholine; Adie Syndrome; Adult; Biopsy; Carbachol; Cystoscopy; Dexametha

1972